Clinical Trials Browser

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT07432984 2026-02-25

FMT-LUNG

Phase 2 Not yet recruiting

15 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07434167 2026-02-25

Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules

Phase NA Not yet recruiting

30 enrolled

Thoracic

Lung Neoplasms

NCT07322367 2026-02-24

A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients

Phase NA Not yet recruiting

27,000 enrolled

Thoracic

Lung Neoplasms

NCT06552000 2026-02-23

Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer

Phase NA Not yet recruiting

18 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07382726 2026-02-20

Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial

Phase 1 Not yet recruiting

18 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

Phase EARLY_PHASE1 Not yet recruiting

24 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT06943664 2026-02-18

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

27 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07418866 2026-02-18

FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

70 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07418879 2026-02-18

A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLC

Phase NA Not yet recruiting

25 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07418931 2026-02-18

CECYDE

Phase 2 Not yet recruiting

108 enrolled

Thoracic

Advanced Squamous Non-Small Cell Lung Cancer

NCT07412041 2026-02-17

PERCC

Phase NA Not yet recruiting

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07412262 2026-02-17

A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer With Acquired Resistance to Immunotherapy and High YAP Protein Expression

Phase 2 Not yet recruiting

32 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07412327 2026-02-17

A Single-Center, Prospective Phase II Clinical Study of Proton Beam Intensity-Modulated Stereotactic Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

Phase NA Not yet recruiting

65 enrolled

Thoracic

Lung Neoplasms

Clinical Trials

RICEPS-2

Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors

PREHAB

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

PulmoSalud: Multimodal Program for Prehabilitation and Early Home Rehabilitation in Patients With Lung Cancer

Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

GIVEN

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

AmiCARE

DK222 Study at Hopkins

CARE Tool Study Aim 3

Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT

Video Double-Lumen Tube for Secondary Pulmonary Resection

SCLC Tarlatamab Blood Collection

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer

SPARC

EBUS

An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases

Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiotherapy for Primary Tumors in Non-Oligometastatic Stage IV Non-Small Cell Lung Cancer

The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk

Therapy for Advanced NSCLC With EGFR 19delins Mutation

A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

P4-PACIFIC

CURB-TKI

LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living With Metastatic Lung Cancer

T-BRAIN

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

RIOT 4B

STRADOS

3D Virtual Resection for Predicting Lung Function in VATS

QVA-Mod

DETERMINE

FMT-LUNG

Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules

A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients

Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer

Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer

A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLC

CECYDE

PERCC

A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer With Acquired Resistance to Immunotherapy and High YAP Protein Expression

A Single-Center, Prospective Phase II Clinical Study of Proton Beam Intensity-Modulated Stereotactic Radiotherapy for Early-Stage Non-Small Cell Lung Cancer